CODX ▲ +7.3% - Co-Diagnostics, Inc.
$CODX CODX - Co-Diagnostics' Joint Venture CoSara Diagnostics Completes Clinical Study and Regulatory Submission for Point-of-Care Tuberculosis Test, Sets Stage for Commercial Launch in India
27-OCT-2026 07:45 AM ET
Share this post
More filings for $CODX
CODX ▼ -3.0% - Co-Diagnostics, Inc.Oct 20, 2026CODX ▲ +2.6% - Co-Diagnostics, Inc.Oct 15, 2026CODX ▼ -0.9% - Co-Diagnostics, Inc.Oct 8, 2026CODX ▲ +1.8% - Co-Diagnostics, Inc.Oct 6, 2026CODX ▲ +2.1% - Co-Diagnostics, Inc.Sep 21, 2026CODX ▼ -1.7% - Co-Diagnostics, Inc.Sep 16, 2026
View full $CODX filing history →💬 Comments
Loading comments…
Leave a comment